5.1. Analysis.
Comparison 5 Thirty‐day prophylactic low molecular weight heparin (LMWH) versus 30‐day intermediate LMWH, Outcome 1 Venous thromboembolism end‐of‐treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.